Acute myeloid leukemia driven by tandem duplications within the UBTF gene (UBTF-TD AML) is a high-risk pediatric cancer in ...

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

Brains with chronic traumatic encephalopathy (CTE) show DNA damage similar to Alzheimer’s. Study links genetic stress to ...

Within each cell, there is a constant struggle between life-sustaining molecules and molecules that could hasten its demise.

An artificial intelligence model predicts how brain immune cells react to RNA and DNA nanoparticles, helping scientists design safer and more effective nucleic acid therapies faster.

Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...

Tardigrades make a unique damage suppressor protein that researchers are working to harness for medicine, space, agriculture, ...

Winston Timp, the principal investigator of the Timp Lab and associate professor of Biomedical Engineering (BME) at the ...

Immune checkpoint inhibitors (ICIs) emerged in the US about 15 years ago as an exciting class of cancer treatments that have ...

The company is developing blood tests for chronic diseases using artificial intelligence models and a database of more than 400,000 tissue samples.

Research institutes are projected to capture 50% of total market revenue in 2025, reflecting their pivotal role in genomic innovation. These institutions rely heavily on high-throughput sequencing ...

Twist Bioscience is advancing synthetic DNA manufacturing with innovation but remains at the lower end of its 52-week range.